Imaging and fluid biomarkers in frontotemporal dementia
暂无分享,去创建一个
[1] H. Mitsumoto,et al. [A prognostic biomarker in amyotrophic lateral sclerosis]. , 2018, Rinsho shinkeigaku = Clinical neurology.
[2] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[3] William T. Hu,et al. Poly(Gp) Proteins Are A Useful Pharmacodynamic Marker For C9Orf72-Associated Amyotrophic Lateral Sclerosis , 2017 .
[4] K. Blennow,et al. Blood-based NfL , 2017, Neurology.
[5] Virginia M. Y. Lee,et al. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies , 2017, Brain : a journal of neurology.
[6] De La Sayette,et al. Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET , 2017, Brain Imaging and Behavior.
[7] D. Lulé,et al. Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[8] Keith A. Johnson,et al. Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies , 2017, Annals of neurology.
[9] C. Rowe,et al. Tau imaging with [18F]THK‐5351 in progressive supranuclear palsy , 2017, European journal of neurology.
[10] D. Kasselimis,et al. Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia. , 2016, Journal of Alzheimer's disease : JAD.
[11] Rebecca M. E. Steketee,et al. Multiparametric computer-aided differential diagnosis of Alzheimer’s disease and frontotemporal dementia using structural and advanced MRI , 2016, European Radiology.
[12] A. Takeda,et al. In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET , 2016, Neurology.
[13] O. Hansson,et al. Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy , 2016, Acta Neuropathologica.
[14] Y. Pijnenburg,et al. Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study. , 2016, Journal of Alzheimer's Disease.
[15] E. Westman,et al. Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors. , 2016, Journal of Alzheimer's disease : JAD.
[16] M. Jorge Cardoso,et al. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia , 2016, Neurology.
[17] D. Perani,et al. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia , 2016, Journal of Alzheimer's disease : JAD.
[18] E. Hornstein,et al. Vulnerability of microRNA biogenesis in FTD–ALS , 2016, Brain Research.
[19] G. Jicha,et al. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] N. Schuff,et al. Diagnostic utility of ASL‐MRI and FDG‐PET in the behavioral variant of FTD and AD , 2016, Annals of clinical and translational neurology.
[21] Nick C Fox,et al. Advances in neuroimaging in frontotemporal dementia , 2016, Journal of neurochemistry.
[22] Y. Pijnenburg,et al. Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers , 2016, Dementia and Geriatric Cognitive Disorders Extra.
[23] M. Staufenbiel,et al. Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases , 2016, Neuron.
[24] S. Ourselin,et al. Neurofilament light chain: a biomarker for genetic frontotemporal dementia , 2016, Annals of clinical and translational neurology.
[25] O. Hansson,et al. 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers , 2016, Brain : a journal of neurology.
[26] K. Blennow,et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis , 2016, The Lancet Neurology.
[27] M. Synofzik,et al. Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[28] Michelle K. Cahill,et al. Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation , 2016, Cell.
[29] C. Heyser,et al. Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs , 2016, Neuron.
[30] J. Rowe,et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes , 2016, Neurology.
[31] Olivier Piguet,et al. On the right side? A longitudinal study of left- versus right-lateralized semantic dementia. , 2016, Brain : a journal of neurology.
[32] R. Rademakers,et al. Genetics of FTLD: overview and what else we can expect from genetic studies , 2016, Journal of neurochemistry.
[33] A. Picco,et al. Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[34] Junming Shao,et al. Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study , 2016, The Journal of Nuclear Medicine.
[35] Nick C Fox,et al. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases , 2016, Brain : a journal of neurology.
[36] A. Boxer,et al. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD , 2016, Journal of Neural Transmission.
[37] K. Blennow,et al. Plasma neurofilament light chain predicts progression in progressive supranuclear palsy , 2016, Annals of clinical and translational neurology.
[38] S. Rombouts,et al. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study☆ , 2016, NeuroImage: Clinical.
[39] Y. Pijnenburg,et al. Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics , 2016, Alzheimer's & dementia.
[40] N. Tomita,et al. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration , 2016, Journal of neurochemistry.
[41] K. Blennow,et al. CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease , 2016, Annals of clinical and translational neurology.
[42] S. Mead,et al. Review: An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations , 2015, Neuropathology and applied neurobiology.
[43] W. M. van der Flier,et al. Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes , 2015, Alzheimer's & dementia.
[44] K. Blennow,et al. Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease , 2015, Annals of clinical and translational neurology.
[45] J. Hodges,et al. Divergent Longitudinal Propagation of White Matter Degradation in Logopenic and Semantic Variants of Primary Progressive Aphasia. , 2015, Journal of Alzheimer's disease : JAD.
[46] D. Galimberti,et al. Inflammatory molecules in Frontotemporal Dementia: Cerebrospinal fluid signature of progranulin mutation carriers , 2015, Brain, Behavior, and Immunity.
[47] K. Blennow,et al. Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[48] Jeroen van der Grond,et al. Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's disease , 2015, Front. Hum. Neurosci..
[49] L. Wilkins. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis , 2015, Neurology.
[50] Stanley Durrleman,et al. Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease? , 2015, Journal of Alzheimer's disease : JAD.
[51] M. Filippi,et al. MRI signatures of the frontotemporal lobar degeneration continuum , 2015, Human brain mapping.
[52] P. Steinacker,et al. Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives. , 2015, Biochimica et biophysica acta.
[53] N. Pearce,et al. Neurofilament light chain , 2015, Neurology.
[54] Marion Smits,et al. Early-stage differentiation between presenile Alzheimer’s disease and frontotemporal dementia using arterial spin labeling MRI , 2015, European Radiology.
[55] C. Jack,et al. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images , 2015, European journal of neurology.
[56] Mike P. Wattjes,et al. Cerebral perfusion and glucose metabolism in Alzheimer’s disease and frontotemporal dementia: two sides of the same coin? , 2015, European Radiology.
[57] M. Fernández-Matarrubia,et al. Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes , 2015, Journal of Neurology.
[58] J. Trojanowski,et al. TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies , 2015, Acta neuropathologica communications.
[59] S. Sorbi,et al. Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia , 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[60] P. Hartikainen,et al. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Patients with Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis with the C9ORF72 Repeat Expansion , 2015, Dementia and Geriatric Cognitive Disorders.
[61] Veeranna,et al. Neurofilament Subunits are Integral Components of Synapses and Modulate Neurotransmission and Behavior In Vivo , 2015, Molecular Psychiatry.
[62] Robert I. Reid,et al. Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia , 2015, Brain and Language.
[63] Veronica Redaelli,et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis , 2015, The Lancet Neurology.
[64] D. Neary,et al. Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration , 2015, Neurobiology of Aging.
[65] Christopher C Rowe,et al. Tau imaging: early progress and future directions , 2015, The Lancet Neurology.
[66] G. Zaharchuk,et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. , 2015, Magnetic resonance in medicine.
[67] G. Magnani,et al. Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia. , 2014, Journal of Alzheimer's disease : JAD.
[68] Karmen K. Yoder,et al. Cerebral hypometabolism and grey matter density in MAPT intron 10 +3 mutation carriers. , 2014, American journal of neurodegenerative disease.
[69] K. Blennow,et al. CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival , 2014, Neurology.
[70] Nick C Fox,et al. Longitudinal Diffusion Tensor Imaging in Frontotemporal Dementia , 2014, Annals of neurology.
[71] Giovanni Coppola,et al. Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. , 2014, Brain : a journal of neurology.
[72] K. Ishii. PET Approaches for Diagnosis of Dementia , 2014, American Journal of Neuroradiology.
[73] M. Filippi,et al. Disrupted brain connectome in semantic variant of primary progressive aphasia , 2014, Neurobiology of Aging.
[74] Franco Cauda,et al. Multimodal fMRI Resting-State Functional Connectivity in Granulin Mutations: The Case of Fronto-Parietal Dementia , 2014, PloS one.
[75] Peter K. Todd,et al. Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS , 2014, Neuron.
[76] L. Ungar,et al. The power of neuroimaging biomarkers for screening frontotemporal dementia , 2014, Human brain mapping.
[77] A. Drzezga,et al. Imaging Frontotemporal Lobar Degeneration , 2014, Current Neurology and Neuroscience Reports.
[78] S. Lui,et al. Anatomical deficits in adult posttraumatic stress disorder: A meta-analysis of voxel-based morphometry studies , 2014, Behavioural Brain Research.
[79] A. Laird,et al. Conceptualizing neuropsychiatric diseases with multimodal data-driven meta-analyses – The case of behavioral variant frontotemporal dementia , 2014, Cortex.
[80] Patrizia Rizzu,et al. Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia , 2013, Neurology.
[81] Mike P. Wattjes,et al. Distinct perfusion patterns in Alzheimer’s disease, frontotemporal dementia and dementia with Lewy bodies , 2014, European Radiology.
[82] J. Molinuevo,et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.
[83] J. Hodges,et al. Longitudinal white matter changes in frontotemporal dementia subtypes , 2014, Human brain mapping.
[84] S. Engelborghs,et al. TDP-43 AS A BIOMARKER FOR FRONTOTEMPORAL LOBE DEGENERATION: A SYSTEMATIC REVIEW OF EXISTING ANTIBODIES , 2014, Alzheimer's & Dementia.
[85] Michael T. Heneka,et al. Innate immune activation in neurodegenerative disease , 2014, Nature Reviews Immunology.
[86] J. Hodges,et al. Phonologic errors as a clinical marker of the logopenic variant of PPA , 2014, Neurology.
[87] C. Nilsson,et al. Age-Related Incidence and Family History in Frontotemporal Dementia: Data from the Swedish Dementia Registry , 2014, PloS one.
[88] Cindee M. Madison,et al. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology , 2014, NeuroImage: Clinical.
[89] Nick C Fox,et al. Profiles of white matter tract pathology in frontotemporal dementia , 2014, Human brain mapping.
[90] A. Chiò,et al. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[91] L. Grinberg,et al. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration , 2014, Annals of neurology.
[92] J. Molinuevo,et al. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[93] Chadwick M. Hales,et al. Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP , 2013, Neurology.
[94] V. Sossi,et al. Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers , 2013, Neurology.
[95] Didier Dormont,et al. Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation. , 2013, Brain : a journal of neurology.
[96] Massimo Filippi,et al. Functional network connectivity in the behavioral variant of frontotemporal dementia , 2013, Cortex.
[97] B. Miller,et al. Anterior temporal lobe degeneration produces widespread network-driven dysfunction. , 2013, Brain : a journal of neurology.
[98] Sandra E Black,et al. Salience network resting-state activity: prediction of frontotemporal dementia progression. , 2013, JAMA neurology.
[99] Bryan J. Traynor,et al. GroupICA dual regression analysis of resting state networks in a behavioral variant of frontotemporal dementia , 2013, Front. Hum. Neurosci..
[100] Cheryl L. Grady,et al. Abnormal network connectivity in frontotemporal dementia: Evidence for prefrontal isolation , 2013, Cortex.
[101] Nick C Fox,et al. White matter tract signatures of the progressive aphasias , 2013, Neurobiology of Aging.
[102] C. Nilsson,et al. Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia , 2013, BMC Neurology.
[103] H. Rosen,et al. Neuroimaging in frontotemporal dementia , 2013, International review of psychiatry.
[104] Elizabeth Rochon,et al. Whole‐brain white matter disruption in semantic and nonfluent variants of primary progressive aphasia , 2013, Human brain mapping.
[105] E. Kremmer,et al. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.
[106] B. Avants,et al. White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[107] N. Schuff,et al. MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes. , 2012, Journal of Alzheimer's disease : JAD.
[108] C. Caltagirone,et al. Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD , 2012, Neurobiology of Aging.
[109] D. Geschwind,et al. Frontotemporal dementia due to C9ORF72 mutations , 2012, Neurology.
[110] J. Gee,et al. White matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration , 2012, Neurology.
[111] Q. Gong,et al. Gray Matter Atrophy in Behavioral Variant Frontotemporal Dementia: A Meta-Analysis of Voxel-Based Morphometry Studies , 2012, Dementia and Geriatric Cognitive Disorders.
[112] Murray Grossman,et al. CSF biomarkers cutoffs: the importance of coincident neuropathological diseases , 2012, Acta Neuropathologica.
[113] C. Jack,et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics , 2012, Brain : a journal of neurology.
[114] J. Whitwell,et al. Neuroimaging in frontotemporal lobar degeneration—predicting molecular pathology , 2012, Nature Reviews Neurology.
[115] L. Agnati,et al. Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian Study , 2011, Neurodegenerative Diseases.
[116] G. Frisoni,et al. Functional network disruption in the degenerative dementias , 2011, The Lancet Neurology.
[117] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[118] David T. Jones,et al. Altered functional connectivity in asymptomatic MAPT subjects , 2011, Neurology.
[119] D. Galimberti,et al. Faculty Opinions recommendation of Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia. , 2011 .
[120] M Filippi,et al. Whole brain structural changes predict the mild cognitive impairment to Alzheimer's disease conversion: Evidence from the Alzheimer's Disease Neuroimaging Initiative , 2011, Alzheimer's & Dementia.
[121] S. Cappa,et al. White matter damage in frontotemporal lobar degeneration spectrum , 2011, Alzheimer's & Dementia.
[122] J. Hodges,et al. Neuropathological background of phenotypical variability in frontotemporal dementia , 2011, Acta Neuropathologica.
[123] Theresa M. Harrison,et al. Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia , 2011, Neurology.
[124] Robert V Farese,et al. Suberoylanilide Hydroxamic Acid (Vorinostat) Up-regulates Progranulin Transcription , 2011, The Journal of Biological Chemistry.
[125] Karsten Mueller,et al. Combined Evaluation of FDG-PET and MRI Improves Detection and Differentiation of Dementia , 2011, PloS one.
[126] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[127] Sébastien Ourselin,et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations☆ , 2010, NeuroImage.
[128] Nick C Fox,et al. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[129] J. Trojanowski,et al. Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia , 2010, Neurology.
[130] C. Jack,et al. Caudate atrophy on MRI is a characteristic feature of FTLD‐FUS , 2010, European journal of neurology.
[131] J. Trojanowski,et al. Novel CSF biomarkers for frontotemporal lobar degenerations , 2010, Alzheimer's & Dementia.
[132] Efstathios D. Gennatas,et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. , 2010, Brain : a journal of neurology.
[133] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[134] J. V. van Swieten,et al. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration , 2009, Journal of Neurology.
[135] Matthew L Senjem,et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. , 2009, Brain : a journal of neurology.
[136] J. Brewer. Fully-Automated Volumetric MRI with Normative Ranges: Translation to Clinical Practice , 2009, Behavioural neurology.
[137] Norbert Schuff,et al. White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI , 2009, Brain : a journal of neurology.
[138] Nick C Fox,et al. Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration , 2009, Neurology.
[139] R. Petersen,et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members , 2009, Brain : a journal of neurology.
[140] W. Jagust,et al. Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia , 2008, Annals of neurology.
[141] D Perani,et al. Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. , 2008, Rejuvenation research.
[142] J. Trojanowski,et al. CSF biomarkers in frontotemporal lobar degeneration with known pathology , 2008, Neurology.
[143] P. Carmeliet,et al. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival , 2008, The Journal of cell biology.
[144] Maria Luisa Gorno-Tempini,et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. , 2008, Archives of neurology.
[145] N. Bresolin,et al. Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration , 2008, Journal of Neurology.
[146] Michael D Greicius,et al. Divergent Social Functioning in Behavioral Variant Frontotemporal Dementia and Alzheimer Disease: Reciprocal Networks and Neuronal Evolution , 2007, Alzheimer disease and associated disorders.
[147] D. Yves von Cramon,et al. Towards a nosology for frontotemporal lobar degenerations—A meta-analysis involving 267 subjects , 2007, NeuroImage.
[148] A. Drzezga,et al. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study , 2007, Neurobiology of Aging.
[149] Elisabeth Kapaki,et al. Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia , 2006, Journal of the Neurological Sciences.
[150] N. Schuff,et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI , 2006, Neurology.
[151] A. Drzezga,et al. Longitudinal Changes of Cerebral Glucose Metabolism in Semantic Dementia , 2006, Dementia and Geriatric Cognitive Disorders.
[152] S. Melquist,et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.
[153] N. Bresolin,et al. Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration , 2006, Neurology.
[154] M. Weiner,et al. Cognition and anatomy in three variants of primary progressive aphasia , 2004, Annals of neurology.
[155] P. Scheltens,et al. Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations. , 2003, Archives of neurology.
[156] C. Baird,et al. The pilot study. , 2000, Orthopedic nursing.
[157] L S Illis,et al. Spinal cord stimulation in multiple sclerosis: clinical results. , 1980, Journal of neurology, neurosurgery, and psychiatry.
[158] María Blanca Fernández-Viñéa. CURRENT STATUS AND FUTURE PERSPECTIVES , 2018 .
[159] B. Borroni,et al. Looking for Neuroimaging Markers in Frontotemporal Lobar Degeneration Clinical Trials: A Multi-Voxel Pattern Analysis Study in Granulin Disease. , 2016, Journal of Alzheimer's disease : JAD.
[160] F. Islami,et al. Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran , 2016, Medicine.
[161] P. Scheltens,et al. Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes. , 2016, Journal of Alzheimer's disease : JAD.
[162] Simone Lista,et al. Biomarkers in Sporadic and Familial Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.
[163] H. Struyfs,et al. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis. , 2015, Journal of Alzheimer's disease : JAD.
[164] J. Clarimón,et al. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.
[165] Paul M Thompson,et al. Regional differences in white matter breakdown between frontotemporal dementia and early-onset Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.
[166] J. Pariente,et al. Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers. , 2012, Journal of Alzheimer's disease : JAD.
[167] Nick C Fox,et al. Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration. , 2012, Journal of Alzheimer's disease : JAD.
[168] C. Nilsson,et al. Diagnosis of frontotemporal dementia in Sweden. Data from the Swedish Dementia Registry. , 2012 .
[169] N. Bresolin,et al. Cerebrospinal fluid biomarkers in Progranulin mutations carriers. , 2011, Journal of Alzheimer's disease : JAD.
[170] Nancy Reagan,et al. Consensus Report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease" , 1998 .